All News

Found 9,485 articles

• Radiant Medical Announces Guido J. Neels Joins Board Of Directors

  5/11/2006

• YM BioSciences Completes Acquisition Of EXIMIAS Pharmaceutical Corporation

  5/10/2006

• Aastrom Biosciences, Inc. Reports Third Quarter Fiscal Year 2006 Financial Results

  5/10/2006

• Corcept Therapeutics Inc. Announces First Quarter 2006 Results

  5/10/2006

• Eli Lilly and Company To Extend Patient Assistance Programs For Medicare Patients

  5/10/2006

• Eli Lilly and Company Submits Cymbalta(R) Supplemental New Drug Application For Generalized Anxiety Disorder

  5/9/2006

• Serono International S.A. Announces New Appointments To Its Executive Management Board

  5/9/2006

• Emisphere Technologies, Inc. Announces 2006 First Quarter Preliminary Financial Results

  5/5/2006

• Jury Rules In Favor Of Ariad Pharmaceuticals, Inc. And Co-Plaintiffs In Eli Lilly and Company NF-(kappa)B Patent Infringement Lawsuit

  5/4/2006

• Jury Issues Verdict In Ariad Pharmaceuticals, Inc. v. Eli Lilly and Company Patent Infringement Suit

  5/4/2006

• ZymoGenetics, Inc. Reports First Quarter 2006 Financial Results

  5/4/2006

• Isis Pharmaceuticals, Inc. Reports Financial Results And Highlights For First Quarter Of 2006

  5/3/2006

• Ignite Health Wins Interactive Agency Assignment From Cephalon, Inc. Oncology

  5/2/2006

• Altair Nanotechnologies Signs Agreement With Eli Lilly and Company

  5/2/2006

• Emisphere Technologies, Inc. To Receive Milestone Payment For eligen(R) Technology To Be Used In New Development Program

  5/1/2006

• Cleveland Clinic to Host National Summit on Biomedical Conflicts Of Interest Sept. 20

  5/1/2006

• Sigma-Aldrich Corporation Sponsors Full-Text Article On High Content Viral Library Screens

  4/27/2006

• Amylin Pharmaceuticals, Inc. Reports First Quarter Financial Results

  4/27/2006

• Strategic Research Institute Release: The World Antibody Community To Convene At Antibody Manufacturing & Production Conference June 12-14, 2006 In San Francisco, CA

  4/27/2006

• Eli Lilly and Company And Alkermes Initiate Additional Phase 3 Study For Inhaled Insulin As Part Of Comprehensive Registration Program

  4/26/2006